//Media Centre

You can read about our performance, latest achievements and important announcements and activities throughout the year. Connect with us on social media to keep on top of our latest news and opinions.

Follow us on small-icon-vimeo Vimeo small-icon-twitter Twitter and small-icon-in LinkedIn.

Media Contacts

PRnews_361Our media team are available for accredited media enquiries only.

 

Media contact:
John Kelly
Chief Executive

Tel: +61 (0)2 9099 4750

Company Brochure

For an overview of our products and services, download the latest Company Brochure

AtomoRapid™ HIV Brochure

For an overview of Atomo’s award-winning professional use HIV test, download the Product Brochure

Atomo HIV Self Test Brochure

For an overview of Atomo’s safe, convenient and accurate HIV self-test product, download the Product Brochure

OEM Services Brochure

downloadbrochureDownload our OEM services brochure to find out more about our custom device manufacturing services.

 

Company Fact Sheet

For a snapshot view of our current company profile, download the latest Fact Sheet

 

Latest press releases

1010, 2017

PRESS RELEASE: CE Marking for world’s only integrated HIV Self-Test from Atomo Diagnostics gives access to safe, accurate and reliable self-testing

  SYDNEY, AUSTRALIA, October 10, 2017 – Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that its Atomo HIV Self Test has been granted CE Marking by a European Union [...]

3005, 2017

Atomo Diagnostics’ HIV Self Test receives approval from Kenya Ministry of Health

Sydney, Australia, May 30, 2017| Multi-award winning medical device innovator Atomo Diagnostics today announced its pioneering HIV self test product has been approved for sale in Kenya. Following successful product evaluations and in-field studies conducted [...]

102, 2017

Atomo Diagnostics receives further international financing

SYDNEY, Australia, 1 February  2017: Medical device innovator Atomo Diagnostics today announced it had received US$1 million (A$1.31 million, C$1.32 million) in financing from Grand Challenges Canada to support its continued business operations. Funded by the [...]

811, 2016

NG Biotech To Unveil Next Generation Integrated hCG Rapid Diagnostic Blood Test, Developed In Conjunction With Atomo Diagnostics

Guipry, France and Sydney, Australia, 8 November 2016 - French biotechnology company, NG Biotech, and Australian medical device innovator, Atomo Diagnostics, announced today that they have developed the world’s first fully-integrated blood-based rapid test for [...]

2710, 2016

Atomo Diagnostics receives grant to develop new, innovative HIV self-test solution

Self-testing is increasingly recognized for its potential to revolutionize HIV diagnosis and reach at-risk individuals who do not know their HIV status. This has the potential to improve detection rates in key populations. Self-testing is [...]

1108, 2016

Atomo Diagnostics secures $4.5 million in funding from New York-based Global Health Investment Fund and former Macquarie Group CEO Allan Moss

SYDNEY, Australia 11 August 2016 | Medical device innovator Atomo Diagnostics today announced it had raised A$4.5 million in new equity funding from a number of professional investors including the New York-based Global Health Investment [...]